LIRAGLUTIDE 5-PAK 18 MG/3 ML
For 15 mL
Pharmacies pay
$738.72 filed
15 × $49.24809 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$1,127.32 filed
15 × $75.15488 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.5× estimated
Medicare paid 1.5× what pharmacies pay.
Part D averages every strength and form sold under “Liraglutide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$854.53 estimated
$738.72 + $110.81 (15%) + $5.00 fee per fill = $854.53
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LIRAGLUTIDE 5-PAK 18 MG/3 ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as liraglutide.
FDA gives its dosage form as injection, solution and its route as subcutaneous.
Its labelers, the companies named on the label, are Teva Pharmaceuticals, Inc., Cipla USA Inc. and Biocon Pharma Inc.
FDA’s Established Pharmacologic Class for it is GLP-1 Receptor Agonist.
The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $738.72 for 15 mL (15 × $49.24809 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
All 3 NDCs
- 00480-7250-46 · Teva Pharmaceuticals, Inc. · $49.24809 per ML · eff. 2026-09-23 filed
- 69097-0910-55 · Cipla USA Inc. · $49.24809 per ML · eff. 2026-09-23 filed
- 70377-0095-53 · Biocon Pharma Inc. · $49.24809 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name liraglutide with LIRAGLUTIDE 5-PAK 18 MG/3 ML.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LIRAGLUTIDE 2-PAK 18 MG/3 ML | $31.40617 per ML filed | $75.15488 per ML filed |
| LIRAGLUTIDE 3-PAK 18 MG/3 ML | $30.63238 per ML filed | $75.15488 per ML filed |
| LIRAGLUTIDE 5-PAK 18 MG/3 ML this page | $49.24809 per ML filed | $75.15488 per ML filed |
| SAXENDA 18 MG/3 ML PEN | $87.12596 per ML filed | We don’t know yet |
| VICTOZA 2-PAK 18 MG/3 ML PEN | $87.748 per ML filed | We don’t know yet |
| VICTOZA 3-PAK 18 MG/3 ML PEN | $87.81962 per ML filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 3 NDCs’ NADAC prices is $49.24809 per ML filed.
Of the 39 other products in FDA’s GLP-1 Receptor Agonist class priced per ML, 37 have a higher middle NADAC price and 2 a lower one. The one in the middle is WEGOVY 1.7 MG/0.75 ML PEN, at $435.55769 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $1,127.32 for 15 mL, at an average of $75.15488 per ML in 2024 (2024-01-01 to 2024-12-31) for “Liraglutide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 62,254 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 15 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 15 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LIRAGLUTIDE 5-PAK 18 MG/3 ML labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Liraglutide / Liraglutide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
- Why does this page start at 15 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 15 mL in one package for all 3 NDCs of this product (“5 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTIC”), so the card starts at one package: 15 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- MOUNJARO 10 MG/0.5 ML PEN
- TRULICITY 0.75 MG/0.5 ML PEN
- RYBELSUS 14 MG TABLET
- SOLIQUA 100 UNIT-33 MCG/ML PEN
- XULTOPHY 100 UNIT-3.6 MG/ML PEN